EUCA4 SAO Week ended 07 Aug 2026

Weekly Investor Report

Eucatex S.A. Indústria e Comércio · Industrials · Building Products & Equipment

Open interactive chart View report data
Latest close 22.61 BRL
-1.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 0.8% above the Trend Line and sits at 57.1% of its 52-week range. The latest completed week returned -1.7%, after a -2.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 47 out of 100
Latest Close 22.61 BRL 7 Aug 2026
1W Return -1.7% latest completed week
4W Return -2.6% short-term follow-through
12W Return -14.4% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 31-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 8 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.7% Latest completed week; four-week move -2.6%. Indicator stack 92/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 2 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 0.8% above the Trend Line and sits at 57.1% of its 52-week range. The latest completed week returned -1.7%, after a -2.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7012-week average 0.90

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.6% over four weeks, -14.4% over 12 weeks, and 35.9% over one year. The current trend has remained active for 31 consecutive weeks.

Performance by holding period

1W-1.7%
4W-2.6%
12W-14.4%
26W13.1%
52W35.9%
Active trend streak31 weeks
Active weeks in one year44
Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.89Latest activity-pressure read.
Pressure change-1942.7%Four-week change in activity pressure.
Leadership10.21Latest relative-leadership reading.
RS change0.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 2 relevant articles.

0 positive · 2 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-19.3%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+15.3%Week of 15 May.
Worst week-7.9%Week of 5 Jun.
Latest week-1.7%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses8
Sharp losses5
Recent vol5.9%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape52/100

Trend, activity pressure, participation, and risk combine to a 52/100 tape read.

 Indicator analysis69/100

Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 12/12.

Activity pressure 0.70; 8 reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 2 relevant articles.

Eucatex Number of Employees 2026 | Employee Count & Headcount Data Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202622.61 BRL-1.7%22.44 BRL15.59 BRL-0.8910.21231.3KOn
31 Jul 202623.00 BRL6.3%22.29 BRL15.51 BRL-0.768.81266.1KOn
24 Jul 202621.64 BRL-3.5%22.11 BRL15.43 BRL-0.574.80265.7KOn
17 Jul 202622.42 BRL-3.4%21.96 BRL15.36 BRL-0.328.83493.2KOn
10 Jul 202623.21 BRL-5.7%21.79 BRL15.29 BRL-0.0410.18368.7KOn
3 Jul 202624.61 BRL3.1%21.57 BRL15.20 BRL0.2619.4774.3KOn
26 Jun 202623.88 BRL-2.6%21.28 BRL15.11 BRL0.3916.8958.8KOn
19 Jun 202624.52 BRL-5.0%21.04 BRL15.02 BRL0.7723.5751.7KOn
12 Jun 202625.80 BRL2.2%20.78 BRL14.92 BRL1.0328.4855.4KOn
5 Jun 202625.25 BRL-7.9%20.47 BRL14.81 BRL1.1627.83107.1KOn
29 May 202627.42 BRL1.0%20.19 BRL14.71 BRL1.1935.44785.1KOn
22 May 202627.15 BRL2.8%19.79 BRL14.59 BRL0.7132.89739.7KOn
15 May 202626.41 BRL15.3%19.41 BRL14.47 BRL0.2029.16954.2KOn
8 May 202622.90 BRL6.6%19.06 BRL14.36 BRL-0.098.62570.9KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context